Microbiology: Antimicrobial Drugs
Chapter 20: Antimicrobial Drugs
Introduction to Antimicrobial Drugs
Chemotherapy: The use of chemicals to treat diseases.
Selective Toxicity: The ability to find and destroy pathogens without harming the host organism.
Antibiotics: Substances produced by microbes that inhibit the growth of other microbes in small amounts.
Antimicrobial Drugs: Synthetic substances that interfere with the growth of microbes.
Historical Background of Chemotherapy
1928: Discovery of penicillin by Alexander Fleming, produced by the mold Penicillium.
1932: Introduction of Prontosil, a red dye, used for treating streptococcal infections.
1940: First clinical trials of penicillin, which paved the way for antibiotic therapy.
Current Challenge: Increasing problem of antibiotic resistance among bacteria.
Sources of Antibiotics
Table 20-1: Representative Sources of Antibiotics
Gram-Positive Rods:
Bacillus subtilis: Produces Bacitracin.
Paenibacillus polymyxa: Produces Polymyxin.
Actinomycetes: Synthesizers of numerous antibiotics including Streptomyces which produces:
Streptomyces griseus: Produces Streptomycin.
Streptomyces aureofaciens: Produces Chloramphenicol.
Saccharopolyspora erythraea: Produces Erythromycin.
Spectrum of Antimicrobial Activity
Narrow Spectrum: Drugs that target a limited range of microbes.
Broad-Spectrum Antibiotics: Effective against a wide variety of gram-positive and gram-negative bacteria.
Superinfection: Occurs when there is an overgrowth of normal microbiota resistant to antibiotics. Examples include Candida albicans and Clostridioides difficile.
Table 20-2: Spectrum of Activity of Antibiotics
Prokaryotes:
Gram-Negative Bacteria: Includes E. coli, Pseudomonas aeruginosa.
Gram-Positive Bacteria: Staphylococcus aureus, Streptococcus pneumoniae.
Eukaryotes:
Fungi: Candida albicans, Cryptococcus.
Protozoa: Giardia intestinalis, Plasmodium (malaria).
Viruses: Examples include HIV, influenza.
Mechanisms of Action of Antimicrobial Drugs
Major Types of Action
Bactericidal: Kill microbes directly.
Bacteriostatic: Inhibit the growth of microbes.
Specific Mechanisms of Action
Inhibiting Cell Wall Synthesis:
Penicillins: Interfere with peptidoglycan synthesis, effective primarily against gram-positive bacteria.
Cephalosporins: Similar mechanism to penicillin but with a different beta-lactam structure.
Inhibiting Protein Synthesis:
Target Bacterial Ribosomes: Apply to 70S ribosomes while human ribosomes are 80S; examples include Streptomycin, Erythromycin.
Injuring the Plasma Membrane:
Polypeptide Antibiotics: Alter permeability of the membrane, examples include Bacitracin and Polymyxin B.
Inhibiting Nucleic Acid Synthesis:
Block DNA replication and transcription; key drugs include Quinolones, Rifamycin.
Inhibiting the Synthesis of Essential Metabolites:
Antimetabolites: Compete with substrates for enzymes. Example: Sulfanilamide competes with para-aminobenzoic acid (PABA).
Antibacterial Drugs Classification
Table 20-3: Antibacterial Drugs by Mode of Action
Inhibitors of Cell Wall Synthesis: Includes natural and semisynthetic penicillins, cephalosporins. e.g.,
Natural Penicillins: Penicillin G (injection) and Penicillin V (oral).
Semisynthetic Penicillins: Ampicillin, Amoxicillin, resistant to penicillinases.
Carbapenems: Imipenem, broad spectrum; Monobactams like Aztreonam.
Inhibitors of Protein Synthesis: Includes Aminoglycosides, Tetracyclines, Macrolides, etc.
Aminoglycosides: Streptomycin, Neomycin, Gentamicin.
Tetracyclines: Broad-spectrum; risk of super-infections, act on tRNA.
Antifungal, Antiviral, Antiprotozoan, and Antihelminthic Drugs
Table 20-5: Classification of Drugs
Antifungal Drugs:
Polyenes (Nystatin, Amphotericin B): Damage membrane sterols.
Azoles (Clotrimazole, Ketoconazole): Inhibit ergosterol synthesis.
Antiviral Drugs:
Nucleoside Analog (e.g., Acyclovir): Block DNA synthesis.
Antiprotozoan Drugs:
Quinine and Chloroquine used to treat malaria.
Antihelminthic Drugs:
Niclosamide inhibits ATP production.
Resistance to Antimicrobial Drugs
Persister Cells: Microbes resistant to antibiotics due to genetic traits.
Superbugs: Antibiotic-resistant bacteria like Acinetobacter baumannii.
Mechanisms of Resistance:
Enzymatic destruction of drugs (e.g., beta-lactamases).
Alteration of drug target sites, e.g., MRSA.
Rapid efflux mechanisms that expel antibiotics from bacterial cells.
Antibiotic Misuse and Prevention
Common Misuses: Include non-prescription availability, incomplete courses, and inappropriate usage for viral infections.
Preventive Measures: Completing prescriptions, avoiding leftovers, and using narrow-spectrum antibiotics.
Future Directions in Antimicrobial Therapy
Targeting virulence factors, utilizing bacteriocins, and incorporating phage therapy in clinical settings.